CClinicalTrials.gg
CompletedNCT05358795Updated Sep 22, 2025

Family Connections Cluster RCT in Zambia

An interventional study of Family Connections in HIV, Adolescent Development and Adolescent Behavior, sponsored by Johns Hopkins Bloomberg School of Public Health. Completed at 1 site in Zambia. Open to participants aged 15 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-09-22.

Sponsored by Johns Hopkins Bloomberg School of Public Health · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
1,386
Allocation
Randomized
Ages
15 Years and older
Sex
All
01

Study summary

This study will evaluate the impact of Family Connections, a family-based group intervention for adolescents and young adults (AYA) living with HIV and their family caregivers, on achieving HIV self-management defined as having an undetectable viral load (VL) and low self-stigma (a score of 1 or less), among older adolescents and young adults (AYA) ages 15-to-21 years. The intervention seeks to increase social and family support and decrease self-stigma among AYA, so they may improve their medication adherence and achieve an undetectable viral load. Findings will fill a critical gap in available evidence-based intervention options for improving the HIV-related outcomes and wellbeing of HIV-positive AYA in sub-Saharan Africa.

Read the detailed description

BACKGROUND/INTRODUCTION

A dearth of programs exist that actively promote HIV self-management among older adolescents and young adults (AYA) in sub-Saharan Africa (SSA). Literature on chronic illness has identified the following skills for promoting self-management: problem-solving, decision-making, resource utilization, formation of a patient-provider partnership, action planning, and self-tailoring skills to one's own situation. While there is an international call to support HIV self-management among adolescents, the reality is that AYAs living with HIV in SSA often do not have access to youth-specific services or opportunities to build life skills. Some clinics hold monthly AYA peer group meetings, however such meetings are typically vulnerable to changes in staff and funding; are often not systematically incorporated into service provision; and do not involve AYAs' family members.

There is also lack evidence on how HIV self-management differs by AYAs' developmental characteristics. Adolescence is a period characterized by intense physical, cognitive, and emotional growth and a desire for independence. Furthermore, data show that some youth living with HIV experience delayed cognitive development, particularly youth that are perinatally infected with HIV. Despite these data, studies rarely examine program impact accounting for variations in AYAs' development. Furthermore, evidence exists that managing chronic illnesses has negative impacts on caregivers and families, particularly in low-income and highly stigmatized environments.

Peer group interventions, however, show promise in reducing HIV-related stigma in SSA among adults and in supporting adolescent ART adherence. Given that HIV is a highly stigmatized chronic illness, peer groups provide a safe environment in which to share experiences and learn from others who understand the day-to-day reality of living with HIV. There is also a growing body of literature from SSA, including Zambia, calling for interventions to involve families in supporting AYA living with HIV to self-manage HIV and to promote family involvement as AYA transition into adulthood and adult HIV services. While experts agree on the need for family-centered approaches and peer support groups, few family-based interventions exist that specifically address the needs of older AYAs aged 15-21 years.

In response to the lack of interventions to promote HIV self-management among AYA that harness the support of caregivers, the study team developed Family Connections- a family group-based intervention. In the study team's earlier pilot study of Family Connections the team adapted an existing adolescent support group guide called Positive Connections (The United States President's Plan for AIDS Relief using mixed-methods formative research. The study team also updated the AYA support group materials and developed a corresponding support group component for caregivers. The feasibility and acceptability of Family Connections was tested in an randomized controlled trial (RCT) among older adolescents (15 to 19 years) and their caregivers in two clinics in Ndola, Zambia. Fifty adolescent/caregiver pairs (100 individuals) were enrolled. Study results found that Family Connections was highly feasible and acceptable. Of the 24 adolescent/caregiver pairs assigned to the intervention arm, 88% attended eight or more of the 10 Family Connections sessions together, and most adolescents (96%) and all caregivers would recommend the intervention to their peers. Although not powered to find differences in outcomes, the prior pilot study showed a signal for efficacy in reducing adolescents' HIV-related feelings of worthlessness (I: 54% to 22% vs. C:38% to 35%, p=0.06) and shame (I: 58% to 30% vs. C:54% to 58%, p=0.07), and reducing caregiver burden (mean scores: I: 0.16 to -0.25 vs. C: -0.15 to -0.25, p=0.08).

Building off this pilot study, this cluster randomized controlled trial (CRCT) will contribute to the field of HIV empirical research and care practices by testing the impact of a feasible and acceptable family-based intervention on increasing the proportion of 15- to 21-year-old AYA who achieve HIV self-management defined as having an undetectable viral load and low self-stigma. This study will also help improve the understanding of how cognitive and developmental processes may moderate intervention outcomes among AYA.

STUDY AIMS:

The specific aims of the research are to:

Aim 1: Assess the impact of Family Connections on achieving HIV self-management defined as having an undetectable viral load (VL \<20 copies/mL) and low self-stigma, among AYA. A cluster randomized controlled trial will be conducted comparing 200 pairs of AYA and caregivers at 10 intervention health facilities versus 200 pairs at 10 control health facilities (n=800 total: 400 AYA, 400 caregivers).

Aim 2: Assess the impact of Family Connections on caregiver burden (e.g., How often does the caregiver feel stressed between caring for adolescent and trying to meet other responsibilities for family or work?) and social support among the 200 AYA caregiver participants in the intervention arm versus the 200 AYA caregiver participants in the control arm (n=400).

Aim 3: Examine if the impact of Family Connections on AYAs' HIV self-management is moderated by developmental differences among youth assessed through measures of cognitive functioning, executive functioning, impulse control, and emotional regulation.

STUDY DESIGN

This study is a multi-site, pair-matched CRCT to evaluate the impact of the Family Connections intervention on achieving undetectable VL among AYA living with HIV. The study team will enroll pairs of AYA living with HIV (ages 15-21) and their caregivers in 20 matched pairs of HIV clinics in Copperbelt Province. The team will enroll and collect baseline data, including a VL test, from an estimated 500 to 700 AYA 15-to-21 years living with HIV in Copperbelt Province and 500 to 700 of their caregivers. The range of participants enrolled is provided as it depends on the proportion of youth initially enrolled who have a detectable VL or high self-stigma at baseline. Based on prior research, approximately 20% of AYA enrolled in the study will have an undetectable viral load. These participants will end study participation at that point. An estimated 35 AYA/caregiver pairs in each clinic will be enrolled until there are approximately 400 AYA participants with a detectable VL or high self-stigma and their caregivers who will continue in the study. After a run-in period, during which study procedures will be refined and facilitators will hold Family Connection sessions, the study will commence in 4 clinics (2-matched pairs) in the Copperbelt Province, and then roll out to the remaining clinics in the Copperbelt. Data collection will occur at baseline, midline (at the end of the Family Connections intervention, approximately six months after baseline), and endline (about six months after midline), and will consist of a survey among caregivers and AYA, a blood draw for AYA, and a point of care (POC) urine adherence test for AYA taking Tenofovir as part of their antiretroviral therapy (ART). The 20 clinics have been pair-matched by number of AYA on ART, and location type. One clinic within each of the matched pairs will be randomly assigned to receive the Family Connections intervention, consisting of 10 in-person group sessions that will take place over an estimated 6 months. The other clinic in the matched pair will be assigned to a standard of care control group. The main comparison will be based on the effect at midline after the 6 months of intervention in the intervention group. Additional contrasts will be tested to examine changes of effects over time (e.g., at endline).

02

Conditions studied

  • HIV
  • Adolescent Development
  • Adolescent Behavior
  • Caregivers
  • Africa

Browse trials for

Keywords

  • HIV
  • Adolescents
  • Youth
  • Caregivers
  • Africa
  • Intervention
03

In context

Adolescent Behavior

69 studies on the registry are indexed under Adolescent Behavior; 22 are open to participants now.

This study's enrollment of 1,386 is above the median of 189 across 62 interventional studies indexed under Adolescent Behavior.

Browse Adolescent Behavior studies →

Lead sponsor

Johns Hopkins Bloomberg School of Public Health is the lead sponsor of 364 studies on the registry; 41 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 3 (60%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
15 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

Eligibility criteria for AYA include:

  • being between 15 and 21 years,
  • HIV positive and aware of their HIV status,
  • on ART for at least 6 months,
  • on first-line ART,
  • living within 30-minutes, by personal transportation, of the clinic by self-report,
  • being available to attend 10 sessions over 6 months,
  • being available for the next 14 months,
  • and speaks one of the study languages, English or Bemba

Eligibility criteria for the caregiver is:

  • being 22 years of age or older,
  • does not work at the study clinic,
  • living within 30-minutes, by personal transportation, of the clinic by self-report,
  • caring for an AYA who meets the study eligibility criteria,
  • being available to attend 10 sessions over 6 months,
  • being available over the next 14 months,
  • and speaks one of the study languages English or Bemba.

Being a biological parent or family member is not an eligibility criterion.

Exclusion criteria

Exclusion Criteria:

The only exclusion criteria are not fulfilling the inclusion criteria.

-

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Sequential assignment
Masking
None (open label)
Enrollment
1,386 participants (actual)

Study arms

  • Experimental
    Family Connections Intervention Arm

    The intervention group sessions aim to 1) improve understanding of HIV among AYA and caregivers; 2) help AYA develop strategies for healthy living (e.g. ART adherence); 3) build AYA capacity to make informed decisions about their sexual and reproductive health; 4) build the capacity of caregivers to support AYA; and 5) help AYA develop life skills to communicate their HIV diagnosis effectively and to plan for their futures. Participants attend group sessions, with caregivers and AYA typically separated for sessions and then brought together sometimes during and sometimes at the end of the sessions, to share information and skills learned. The in-person group intervention will be held twice per month over a period of an estimated 6 months for a total of 10 sessions. Trained facilitators will deliver the intervention at the clinics. Health clinic staff will be available as technical experts to answer clinical questions.

    Behavioral: Family Connections

  • No intervention
    Standard of Care Comparison

    The control group will receive the standard of care during the study for AYA living with HIV in these public health care facilities and communities. The 20 facilities included in the research have been trained to operate under the standard protocols endorsed by the Zambia Ministry of Health. There can be variations in how these standards are adhered to and if special programming is provided for youth, such as youth group meetings and special youth clinic hours. Standard of care services per the 2020 Zambia Consolidated Guidelines include routine clinical care for HIV treatment including laboratory testing (CD4, VL tests); adherence counseling, with enhanced adherence counseling for clients with unsuppressed viral loads; multi-month dispensing of ART including differentiated service delivery for stable clients; screening and treatment of sexually transmitted infections (STIs); prevention and screening for opportunistic infections; and clinical monitoring of kidney and liver function.

Interventions

  • BehavioralFamily Connections

    Family Connections is based on the WHO endorsed Positive Connections manual.

06

What researchers measure

Primary outcomes

  1. Number of participants with undetectable viral load and low self-stigma

    Defined as having \<20 RNA copies/mL and scoring 1 or less on a 3 point self-stigma scale among adolescent and youth participants

    Time frame: ~ 6 months from baseline to midline

Secondary outcomes

  1. Number of caregivers experiencing caregiver burden measured using the Zarit Burden Interview

    Zarit Burden Interview adapted 12-item 3 point Likert-scale (0=never, 1=sometimes, 2=Always) with higher scores indicating more challenges/burdens experienced in caregiving (among caregivers)

    Time frame: ~ 6 months from baseline to midline

  2. Number of caregivers with higher social support measured with Medical Outcomes Study Social Support Survey (MOS-SS)

    Medical Outcomes Study Social Support Survey (MOS-SS), 20-items, 5-point Likert Scales (1=none of the time; 2= a little of the time; 3= some of the time; 4=most of the time, 5=all of the time), with higher scores indicating receipt of greater social support (among caregivers)

    Time frame: ~ 6 months from baseline to midline

  3. Number of adolescent and youth participants with cognitive challenges assessed using the Patient-Reported Outcomes Measurement Information System (PROMIS) pediatric cognitive function scale

    Patient-Reported Outcomes Measurement Information System (PROMIS) pediatric cognitive function adapted through cognitive interviewing (abbreviated 7-item, 5 point Likert-scales with 5=never; 4= a little of the time; 3= sometimes; 4=most of the time, 5=always), with a higher score assessing more difficulties in cognitive abilities/everyday tasks, in the past 4 weeks.

    Time frame: ~ 6 months from baseline to midline

  4. Number of adolescent and youth participants with emotional regulation challenges measures using the Difficulties in Emotion Regulation Scale (DERS-SF)

    Difficulties in Emotion Regulation Scale (DERS-SF), abbreviated 18-items, 5-point Likert scales (5=never; 4= a little of the time; 3= sometimes; 4=most of the time, 5=always), with a higher score assessing greater difficulties identifying/managing emotions.

    Time frame: ~ 6 months from baseline to midline

07

Study locations

1 site
  • Copperbelt Province Clinics
    Ndola, Copperbelt, Zambia
08

References and documents

Publications

  • Schue JL, Mainga T, Nonyane BA, Peterson TL, Miti S, Chongwe G, McCarraher DR, Denison JA. Impact of a youth and caregiver intervention on HIV self-management among youth living with HIV: a protocol for the Family Connections cluster RCT in Zambia. Trials. 2026 Jan 28;27(1):193. doi: 10.1186/s13063-026-09455-3. PubMed 41606621 ↗

Individual participant data

Plan to share: Yes — Will deposit data into an existing data repository for future research (explain): After the study is completed, the de-identified, archived data will be transmitted to and stored in a Data Repository determined in consultation with the NIH Program Officer, for use by other researchers including those outside of the study. Permission to transmit data to a Data Repository will be included in the informed consent. Blood samples will not be stored for future research purposes.

Supporting information: Study protocol

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 22, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05358795
Lead sponsor
Johns Hopkins Bloomberg School of Public Health
Collaborators
FHI 360, Arthur Davison Children's Hospital, Tropical Diseases Research Centre, National Institute of Mental Health (NIMH)
Responsible party
Sponsor
First posted
May 3, 2022
Start date
Apr 1, 2023
Primary completion
Aug 31, 2025
Completion
Aug 31, 2025
Last update
Sep 22, 2025

Study contacts

Julie A. Denison, PhD
principal investigator · Johns Hopkins Bloomberg School of Public Health
Gershom Chongwe, PhD
principal investigator · Tropical Diseases Research Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion